TIM Q3 Profit Declines; Revenues Down 2.1%

TIM (TIAOF.PK) reported that its Board approved the Financial Report at September 30, 2021. The Group's organic EBITDA in the third quarter was 1.7 billion euros, down 5.9% from prior year. Group After Lease EBITDA was 1.5 billion euros, a decline of 7.6%.

Third quarter profit to owners of the parent declined to 159 million euros from 500 million euros, a year ago. Operating profit (EBIT) was 484 million euros compared to 585 million euros, last year.

Revenues for the third quarter was 3.84 billion euros, down 2.1% from prior year. Revenues from services were 3.5 billion euros, for the quarter. Total operating revenues and other income declined to 3.88 billion euros from 3.93 billion euros.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Teva Pharmaceuticals USA, Inc. has recalled one lot of platelet-reducing drug Anagrelide in the form of capsules due to dissolution test failure detected during routine stability testing, the U.S. Food and Drug Administration, or FDA, said in a statement. The U.S. Food and Drug Administration said it has taken steps to make available millions of cans of additional infant and specialty formula to U.S. consumers in the coming months. Under the agency's recent increased flexibilities, British nutrition products maker Kendal Nutricare will send about 2 million cans of infant formula under the Kendamil brand initially to U.S. beginning in June. Video streaming giant Netflix Inc. announced the availability of a variety of mobile games. Players can download the games directly from the Netflix mobile app. The new games include Dragon Up (East Side Games), Moonlighter (11 Bit Studios), Townsmen - A Kingdom Rebuilt (HandyGames), and Exploding Kittens - The Game (Exploding Kittens Digital).
Follow RTT